HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea · Delayed Price · Currency is KRW 3,010.00
-165.00 (-5.20%)
Oct 12, 2026, 3:30 PM KST
| Market Cap | 265.30B +6.0% |
| Revenue (ttm) | 64.45B +5.2% |
| Net Income | -18.02B |
| EPS | -204.73 |
| Shares Out | 88.14M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 507,168 |
| Open | 3,175.00 |
| Previous Close | 3,175.00 |
| Day's Range | 2,855.00 - 3,175.00 |
| 52-Week Range | 1,342.00 - 4,160.00 |
| Beta | -0.53 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |